Home / Inspections / 1092951

FDA Inspection 1092951 — Bloodworks Northwest

Bloodworks Northwest — FEI 3071915

The FDA completed an inspection of Bloodworks Northwest on April 3, 2019 in Eugene, OR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 3, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Eugene, OR (United States)

Facility

Other inspections at this facility

  • 1237599 (NAI Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 920774 (NAI Thu Apr 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 830314 (VAI Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 797471 (VAI Thu Aug 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 734735 (VAI Mon Jul 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources